MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

MannKind Company Profile (NASDAQ:MNKD)

Consensus Ratings for MannKind (NASDAQ:MNKD) (?)
Ratings Breakdown: 4 Sell Rating(s), 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 1.71)
Consensus Price Target: $2.83 (140.00% upside)

Analysts' Ratings History for MannKind (NASDAQ:MNKD)
Show:
DateFirmActionRatingPrice TargetActions
6/1/2016RBC CapitalLower Price TargetUnderperform$1.00 -> $0.15View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Piper JaffrayLower Price TargetUnderweight$1.50 -> $0.05View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016JMP SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Goldman Sachs Group Inc.Reiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016S&P Equity ResearchLower Price Target$1.12 -> $0.96View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2016JPMorgan Chase & Co.Reiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016Griffin SecuritiesUpgradeNeutral -> Buy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2015Jefferies GroupReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015MLV & Co.Lower Price TargetHold$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2014Evercore ISIDowngradeBuy -> Hold$10.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for MannKind (NASDAQ:MNKD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/9/2016Q116($0.04)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q4($0.05)($0.66)$0.35 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.07)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.08)($0.07)$0.53 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.08)($0.08)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.09)($0.09)$3.13 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q314$0.04($0.09)$66.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.12)($0.19)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114($0.13)($0.14)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2014Q4($0.14)($0.16)$0.43 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2013Q313($0.14)($0.17)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2013Q2 2013($0.14)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.15)($0.15)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2013Q4 2012($0.19)($0.23)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312($0.24)($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012($0.24)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2012($0.23)($0.27)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012($0.32)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.32)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.30)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011($0.29)($0.34)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011($0.40)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for MannKind (NASDAQ:MNKD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.03)($0.03)($0.03)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.03)($0.03)($0.03)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)
Dividend History for MannKind (NASDAQ:MNKD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for MannKind (NASDAQ:MNKD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/17/2016Michael CastagnaInsiderBuy50,000$0.93$46,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Hakan EdstromCEOSell73,460$4.83$354,811.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2015Hakan EdstromCEOSell73,460$5.21$382,726.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Hakan EdstromCEOSell73,460$7.75$569,315.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015David ThomsonVPSell80,000$7.00$560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Diane PalumboVPSell188,999$5.95$1,124,544.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014David ThomsonVPSell118,114$6.14$725,219.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Juergen MartensVPSell63,800$5.48$349,624.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Juergen MartensVPSell417$7.60$3,169.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014David ThomsonVPSell30,000$8.16$244,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2014Juergen MartensVPSell26,458$9.65$255,319.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014Diane PalumboVPSell17,901$10.01$179,189.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Matthew J PfefferCFOSell20,000$10.44$208,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Hakan EdstromCOOBuy1,692$4.42$7,478.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2014Juergen MartensVPSell25,417$10.53$267,641.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2014David ThomsonVPSell30,000$10.51$315,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Juergen MartensVPSell1,458$10.34$15,075.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Diane PalumboVPSell17,902$10.59$189,582.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Juergen MartensVPSell120,000$11.00$1,320,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2014David ThomsonVPSell133,000$9.95$1,323,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014Diane PalumboVPSell52,957$9.50$503,091.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014Juergen MartensVPSell25,000$7.65$191,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Juergen MartensVPSell76,899$7.50$576,742.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Diane PalumboVPSell18,176$7.06$128,322.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Juergen MartensVPSell50,000$5.56$278,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2013Hakan EdstromCOOBuy1,589$4.53$7,198.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Juergen MartensVPSell32,054$5.00$160,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2013David ThomsonVPSell150,000$5.00$750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/29/2013Juergen MartensVPSell48,057$5.01$240,765.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Diane PalumboVPSell25,000$5.02$125,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013David ThomsonVPSell19,204$5.78$110,999.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Juergen MartensVPSell20,000$5.52$110,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Matthew J PfefferCFOSell10,000$8.00$80,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2013Matthew J PfefferCFOSell10,000$7.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2013Diane PalumboVPBuy1,610$1.96$3,155.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2013Matthew J PfefferCFOBuy7,448$1.96$14,598.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Diane PalumboVPSell66,849$7.50$501,367.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Diane PalumboVPSell26,829$5.25$140,852.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Matthew J PfefferCFOSell10,000$5.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2012Matthew J PfefferCFOBuy1,056$1.95$2,059.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2012Alfred E MannMajor ShareholderBuy40,000,000$2.59$103,600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for MannKind (NASDAQ:MNKD)
DateHeadline
06/30/16 05:35 PMMannKind (MNKD) Stock: Don't Miss This Opportunity - Modest Money (press release) (blog)
06/29/16 05:06 PMNew Broker Ratings For MannKind Corporation (MNKD) - FTSE News
06/29/16 05:06 PMAnalysts Review of Stocks: Neovasc Inc. (NASDAQ:NVCN) , MannKind Corporation (NASDAQ:MNKD) - Street Updates
06/27/16 05:07 PMStocks in the News - MannKind Corporation, (NASDAQ:MNKD), Energy Transfer Equity, (NYSE:ETE) - Hot Stocks Point
06/27/16 05:07 PM10 Largest Short Positions In NASDAQ Shocks - 24/7 Wall St.
06/27/16 05:07 PMStock Analysis review: MannKind Corp. (NASDAQ:MNKD) - News Oracle
06/26/16 09:52 AMMannKind (MNKD) Stock Gains While The Market Falls: Here's Why! - aomarkets (registration) (blog)
06/24/16 09:39 AMMannKind Corp. Shares Are Down 28.3% So Far This Year. Here's Why. - A series of announcements have sent the company's shares on a roller coaster ride this year. Here's a recap of what has happened so far, and some advice for investors considering climbing on board.
06/22/16 05:06 PMMannKind Corporation (MNKD) Jumps 10.28% on June 22 - Equities.com
06/22/16 05:06 PMMannKind (MNKD) Stock: Big Gains Ahead! - Modest Money (press release) (blog)
06/22/16 09:58 AMMannKind Corporation (NASDAQ:MNKD) Analyst Rating Consensus - Trade Calls
06/21/16 04:52 PMMannkind Afrezza Launch 2.0: How It Is Different This Time Around - Seeking Alpha
06/20/16 05:15 AMThis Weeks Broker Views For MannKind Corporation (MNKD) - Fiscal Standard
06/19/16 09:15 AMMannKind - Managing Expectations Of An Afrezza Relaunch - Seeking Alpha
06/16/16 05:23 PMNotable Analyst's Ranking Preview: MannKind Corporation (NASDAQ:MNKD) , Allergan plc. (NYSE:AGN) - Street Updates
06/15/16 05:11 PMHC Stocks Analysis: MannKind Corporation (NASDAQ:MNKD), Perrigo Company plc (NYSE:PRGO) - share market updates (press release)
06/14/16 04:58 PMMost Active Stocks Update: MannKind Corp. (NASDAQ:MNKD), Staples, Inc. (NASDAQ:SPLS) - Beacon Chronicle
06/14/16 04:58 PMCompany Update (NASDAQ:MNKD): MannKind Corporation Announces Late-Breaking Data Reinforcing Faster Onset ... - Smarter Analyst
06/14/16 08:48 AMThese Small Cap Stocks Are On The Move -
06/13/16 09:10 AMHow Does MannKind Corporation (MNKD)’s Afrezza Compare With Mealtime Insulin? -
06/13/16 08:08 AMHC Stocks in Front Line: Galena Biopharma Inc (NASDAQ:GALE), MannKind Corporation (NASDAQ:MNKD) - share market updates (press release)
06/12/16 02:09 PMMannKind Announces Late-Breaking Data Reinforcing Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins - [at noodls] - Data presented at ADA show Afrezza has a 25-to 35-minute faster onset of action than Lispro, with a duration that is up to two hours shorter MannKind Corporation reaffirms commitment to Afrezza, the only ...
06/11/16 05:23 PMMannKind Corporation (MNKD) Stock: Collaboration Agreement In Focus - CNA Finance (press release)
06/11/16 07:24 AMIf You Aren't Careful, This Brokerage Fee Could Wipe You Out -
06/10/16 08:34 AMBRIEF-MannKind announces collaboration with JDRF - * MannKind Corp says entered into a collaboration agreement with JDRF
06/10/16 08:00 AMMannKind Announces Collaboration with JDRF - [GlobeNewswire] - VALENCIA, Calif., June 10, 2016-- MannKind Corporation announced today that it has entered into a collaboration agreement with JDRF, the leading global organization funding type 1 diabetes research. The ...
06/10/16 07:10 AMShort Sellers Become More Selective on Major Biotechs -
06/09/16 08:06 AMEarnings Estimates Highlight: HCA Holdings, Inc. (NYSE:HCA), MannKind Corp. (NASDAQ:MNKD) - Beacon Chronicle
06/08/16 08:08 AMOverview of Analysts Suggestions: MannKind Corporation (NASDAQ:MNKD) , Baxter International Inc. (NYSE:BAX) - Street Updates
06/07/16 05:27 PMMannKind Challenges More Difficult Than Some May Think - Seeking Alpha
06/07/16 05:27 PMComprehensive Report on: Textron Inc. (NYSE:TXT), MannKind Corp. (NASDAQ:MNKD) - Beacon Chronicle
06/07/16 01:19 PMWhy MannKind Corp. Stock Sank 29.6% in May -
06/03/16 08:00 AMAnalysts Rating Alert: MannKind Corporation (NASDAQ:MNKD) , Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) - Street Updates - Is storiesAnalysts Rating Alert: MannKind Corporation (NASDAQ:MNKD) , Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)Street UpdatesMannKind Corporation (NASDAQ:MNKD) accumulated +4.90%, closing at $1.04 after floating between $0.99 and $1.04. The company has market capitalization of $446.33M. It has twelve month low of $0.64 and twelve month high of $7.32. The recent traded ...MannKind Corporation (MNKD) Latest Broker ViewsRisers & FallersBrokerage ratings Updates: MannKind Corporation (NASDAQ:MNKD), Incyte Corporation (NASDAQ:INCY)WsNews 4investorsall 8 news articles »
06/02/16 05:34 PMAnalyst's Valuable Buzzers: Galena Biopharma, Inc. (NASDAQ:GALE) , MannKind Corporation (NASDAQ:MNKD) - Street Updates - Analyst's Valuable Buzzers: Galena Biopharma, Inc. (NASDAQ:GALE) , MannKind Corporation (NASDAQ:MNKD)Street UpdatesOn 6/1/2016, shares of Galena Biopharma, Inc. (NASDAQ:GALE) rose +19.34% in trading session and finally closed at $2.16. The company most recent volume stood at 27.8 million shares as compared to average volume of 2.66 million shares. Over the one ...and more »
06/02/16 11:59 AMMannKind Corp. :MNKD-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 -
06/02/16 08:08 AMMannKind Co. (MNKD) PT Lowered to $0.05 at Piper Jaffray - Let Me Know About This - MannKind Co. (MNKD) PT Lowered to $0.05 at Piper JaffrayLet Me Know About ThisMannKind logo MannKind Co. (NASDAQ:MNKD) had its price target cut by research analysts at Piper Jaffray from $1.50 to $0.05 in a research note issued to investors on Wednesday, StockTargetPrices.com reports. The firm presently has an “underweight” ...and more »
06/01/16 08:00 AMTop Equity Manager Still Believes In MannKind -
05/31/16 05:28 PMRecent Analysts Rating Overview: Pfizer, Inc. (NYSE:PFE) , MannKind Corporation (NASDAQ:MNKD) - Street Updates - Recent Analysts Rating Overview: Pfizer, Inc. (NYSE:PFE) , MannKind Corporation (NASDAQ:MNKD)Street UpdatesPfizer, Inc. (NYSE:PFE) accumulated +0.52%, closing at $34.61 after floating between $34.38 and $34.75. The company has market capitalization of $209.90B. It has twelve month low of $28.25 and twelve month high of $36.46. The recent traded volume of ...and more »
05/31/16 12:39 PM3 Billionaires Bet on MannKind Stock -- Should You Follow? - A few billionaire-led funds picked up more than 1 million shares of the troubled company. Is it worth another look?
05/27/16 07:08 AMOverview of Analysts Suggestions: MannKind Corporation (NASDAQ:MNKD) , Relypsa, Inc. (NASDAQ:RLYP) - Street Updates - Overview of Analysts Suggestions: MannKind Corporation (NASDAQ:MNKD) , Relypsa, Inc. (NASDAQ:RLYP)Street UpdatesOn 5/26/2016, shares of MannKind Corporation (NASDAQ:MNKD) fell -2.94% in trading session and finally closed at $0.99. The company most recent volume stood at 4.32 million shares as compared to average volume of 6.69 million shares. Over the one ...and more »
05/26/16 07:23 AMAnalysts Trends to Watch: MannKind Corporation (NASDAQ:MNKD) , ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) - Street Updates - Analysts Trends to Watch: MannKind Corporation (NASDAQ:MNKD) , ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)Street UpdatesMannKind Corporation (NASDAQ:MNKD) accumulated +5.70%, closing at $1.02 after floating between $0.96 and $1.03. The company has market capitalization of $437.74M. It has twelve month low of $0.64 and twelve month high of $7.32. The recent traded ...and more »
05/25/16 05:05 AMThe 5 Most Shorted Nasdaq Stocks: Did Short Sellers Go Away in May? -
05/24/16 03:27 PMMANNKIND CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secur -
05/24/16 07:46 AMHC Stocks Alerts: MannKind Corporation (NASDAQ:MNKD), Merck & Co., Inc. (NYSE:MRK) - share market updates (press release) - share market updates (press release)HC Stocks Alerts: MannKind Corporation (NASDAQ:MNKD), Merck & Co., Inc. (NYSE:MRK)share market updates (press release)Shares of MannKind Corporation (NASDAQ:MNKD) ended Monday session in green amid volatile trading. The shares closed up +0.020 points or 2.20% at $0.934 with 5.14 million shares getting traded. Post opening the session at $0.93, the shares hit an ...and more »
05/23/16 04:10 PMHC Stocks in Drift: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), MannKind Corporation (NASDAQ:MNKD) - share market updates (press release) - share market updates (press release)HC Stocks in Drift: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), MannKind Corporation (NASDAQ:MNKD)share market updates (press release)Shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) ended Friday session in green amid volatile trading. The shares closed up +0.11 points or 3.49% at $3.26 with 5.07 million shares getting traded. Post opening the session at $3.19, the shares hit an ...and more »
05/23/16 03:22 PMThere Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks -
05/23/16 08:59 AMStocks Earnings Analysis Report: MannKind Corporation (MNKD), Sarepta Therapeutics Inc (SRPT) - Beacon Chronicle - Beacon ChronicleStocks Earnings Analysis Report: MannKind Corporation (MNKD), Sarepta Therapeutics Inc (SRPT)Beacon ChronicleLast Trade: The Company closed its last session at $19.15 yesterday with the gain of 8.81%. The market capitalization of the company is $953.79 million, with the average Volume of $9.40 Million. The stock currently has its 52-Week High range of $41.97 ...and more »
05/23/16 08:59 AMBiotech Stocks Update: MannKind Corporation (NASDAQ:MNKD) , Lannett Co Inc (NYSE:LCI) - Is stories - Is storiesBiotech Stocks Update: MannKind Corporation (NASDAQ:MNKD) , Lannett Co Inc (NYSE:LCI)Is storiesMannKind Corporation (NASDAQ:MNKD) increased +0.0657% to $0.9144 while traded 7.35 million shares on 5/20/2016. The stock price negotiated for value between $0.9100 to $0.9404 in recent trading session. During the past 52 weeks, the stock's price ...Analyst Recommendation: MannKind Corporation (NASDAQ:MNKD), Delcath Systems, Inc. (NASDAQ:DCTH)WsNews 4investorsLast Analysts Rating Review: MannKind Corporation (NASDAQ:MNKD) , Horizon Pharma plc (NASDAQ:HZNP)Street Updatesall 7 news articles »
05/20/16 09:38 AMBetter Buy: MannKind Corp. vs. Dexcom - The diabetes epidemic is enormous, but it takes more than a popular product to succeed.
05/19/16 04:11 PMMannKind Corporation (MNKD) Stock: Is Something Big On The Horizons? - CNA Finance (press release) - CNA Finance (press release)MannKind Corporation (MNKD) Stock: Is Something Big On The Horizons?CNA Finance (press release)MannKind Corporation has been an incredibly interesting stock to watch as of late. Over the past year or so, there has been a heavy debate surrounding the stock, and for good reason. You see, the company created Afrezza, an insulin like no other. This ...Biotech Stocks To Focus: MannKind Corporation (NASDAQ:MNKD) , Quintiles Transitional Holdings Inc. (NYSE:Q)Is storiesAnalysts Keeping an Eye on MannKind Corp. (NASDAQ:MNKD)CWRU ObserverOverview of Analysts Suggestions: MannKind Corporation (NASDAQ:MNKD) , Astrazeneca PLC (NYSE:AZN)Street UpdatesZergwatch -Risers & Fallers -Trade Callsall 25 news articles »
About MannKind

MannKind logoMannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: MNKD
  • CUSIP: 56400P20
Key Metrics:
  • Previous Close: $1.16
  • 50 Day Moving Average: $1.03
  • 200 Day Moving Average: $1.22
  • P/E Ratio: N/A
  • P/E Growth: -0.19
  • Market Cap: $497.83M
  • Current Quarter EPS Consensus Estimate: $-0.24 EPS
Additional Links:
MannKind (NASDAQ:MNKD) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha